Avycaz (ceftazidime and avibactam)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) June 2016 ADVERSE REACTIONS Clinical Trial Experience (addition of new paragraph) AVYCAZ was evaluated in four active-controlled...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts